Vaccine Hesitancy

COVID-19 vaccine hesitancy declined in the United States in late 2020 and early 2021, according to a survey of more than 7,000 adults.

Information on the Tdap vaccine was often incomplete on professional websites and incorrect on social media, particularly Facebook and Instagram, according to researchers.

Approximately 20% of patients receiving in-center hemodialysis in the United States expressed hesitancy toward COVID-19 vaccination, according to a joint survey conducted by Stanford University School of Medicine and U.S. Renal Care.

The medical research community’s swift response to the COVID-19 pandemic has led to the development of multiple vaccines within less than a year and the full vaccination of 94 million Americans against the novel coronavirus.

Primary care physicians are often left out of efforts to bring COVID-19 under control in the United States, but increasing their involvement could have a substantial impact on the pandemic, according to experts.

A nudge intended to remind general practice residents to receive an influenza vaccine, though deemed “acceptable,” did not increase uptake, according to researchers.

Survey results showed that slightly more than half of adults in the United States were “very likely” to get a COVID-19 vaccine, researchers wrote in the Journal of Community Health.

With two COVID-19 vaccines from Moderna and Pfizer-BioNTech now in circulation and individuals nationwide receiving their initial doses, patients and providers have questions — a lot of questions.

Few primary care practices have a plan in place to distribute COVID-19 vaccines, according to a recent survey of primary care clinicians.

While experts are optimistic that multiple COVID-19 vaccine products will be available in late 2020 or early 2021, ongoing questions remain surrounding safety, ethics and distribution, according to panelists at ACR Convergence 2020.